Catheter Precision receives first purchase order from Croatian hospital for VIVO.

Catheter Precision, a medical device company, has received its first purchase order from a hospital in Croatia after winning a competitive tender bid. The hospital, Dubrava Hospital, evaluated the VIVO product and found it to have a simple and flexible workflow, as well as accurate maps. The purchase order marks a significant milestone for the company.

FORT MILL, S.C., Sept. 10, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (VTAK - NYSE/American), a U.S.-based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, has announced the receipt of its first purchase order from a hospital in Croatia. This significant milestone follows the company's successful bid in a competitive tender process Catheter Precision Announces Tender Win and First Purchase Order in Croatia^[1].

Dubrava Hospital, one of the leading healthcare institutions in Croatia, completed an evaluation of Catheter Precision's VIVO product, which received positive feedback for its simple and flexible workflow, as well as the accuracy of its maps. Dr. Ivan Zeljkovic, Head of Electrophysiology Lab at Dubrava University Hospital, expressed his satisfaction with the VIVO system, stating that it "exceeded my expectations" in terms of accuracy and potential to enhance procedural efficacy Catheter Precision Announces Tender Win and First Purchase Order in Croatia^[1].

The purchase order from Dubrava Hospital marks a significant milestone for Catheter Precision, indicating growing acceptance and trust in its innovative technologies among leading clinicians and partners across Europe. Fatih Ayoglu, Sales Manager for EMEA & APAC at Catheter Precision Inc., commented, "This milestone reflects the trust and enthusiasm of leading clinicians and partners across Europe who are embracing our technologies to elevate patient care" Catheter Precision Announces Tender Win and First Purchase Order in Croatia^[1].

VIVO, a non-invasive 3D imaging system, enables physicians to identify the origin of ventricular arrhythmias pre-procedure, thereby streamlining workflow and reducing procedure time. It has received marketing clearance from the U.S. FDA and has the CE Mark. The system's ability to enhance procedural efficiency and accuracy is a key factor in its appeal to healthcare institutions like Dubrava Hospital Catheter Precision Announces Tender Win and First Purchase Order in Croatia^[1].

Catheter Precision is an innovative U.S.-based medical device company focused on developing groundbreaking technology for electrophysiology procedures. The company's success in securing its first purchase order from a leading European hospital underscores its potential for continued growth and expansion in the global medical device market Catheter Precision Announces Tender Win and First Purchase Order in Croatia^[1].

Catheter Precision Announces Tender Win and First Purchase Order in Croatia^[1]: https://www.stocktitan.net/news/VTAK/catheter-precision-announces-tender-win-and-first-purchase-order-in-gucherjvrfok.html